Provisionally Interchangeable? FDA Weighs ‘Requirements’ For Pfizer’s Adalimumab
FDA-Approved Abrilada ‘Meets The Standards As An Interchangeable Biosimilar’
Pfizer has responded to Generics Bulletin’s queries regarding its bid to win an interchangeability designation for its Abrilada (adalimumab-afzb) biosimilar to AbbVie’s Humira reference product.
